Intra-articular Tranexamic Acid in Primary Total Knee Arthroplasty Decreases the Rate of Post-operative Blood Transfusions in People with Hemophilia: A Retrospective Case-Control Study
- 10 Downloads
Blood transfusion rates after total knee arthroplasty (TKA) in patients without hemophilia have diminished with the use of a standardized multimodal blood loss prevention method (MBLPM) that includes intra-articular tranexamic acid (TXA) (MBLPM-TXA). However, the topic has not been addressed in people with hemophilia.
Our aim was to investigate whether the MBLPM-TXA prevents blood loss in patients with hemophilia A who undergo TKA, thereby decreasing the need for post-operative blood transfusion.
This retrospective case–control comparative study involved 30 TKA patients who had a severe degree of hemophilia A without inhibitions: one group treated with the MBLPM-TXA (n = 15) and a second group treated without it (n = 15). In all cases, the pre-operative hemoglobin level was greater than 13 g/dL.
The MBLPM-TXA group had a transfusion rate of zero, whereas 46.6% of the patients (seven of 15) in the non–MBLPM-TXA group needed transfusion.
This retrospective case–control study showed that the use of an MBLPM-TXA in patients with hemophilia A who underwent TKA was effective in reducing rates of transfusion. We recommend its use.
Keywordshemophilia total knee arthroplasty post-operative blood loss blood loss prevention tranexamic acid multimodal blood loss prevention method
Compliance with Ethical Standards
Conflict of Interest
E. Carlos Rodriguez-Merchan, MD, PhD, Carlos A. Encinas-Ullan, MD, and Primitivo Gomez-Cardero, MD, declare that they have no conflicts of interest.
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013.
Informed consent was waived from all patients for being included in this study.
Required Author Forms
Disclosure forms provided by the authors are available with the online version of this article.
- 1.De la Corte-Rodriguez H, Rodriguez-Merchan EC, De la Corte-Garcia H. Rehabilitation of joint surgery in hemophiliacs. In: Joint Surgery in the Adult Patient with Hemophilia. Rodriguez-Merchan EC, ed. Cham, Switzerland: Springer International Publishing Switzerland; 2015:89–99.Google Scholar
- 2.Digas G, Koutsogiannis I, Meletiadis G, Antonopoulou E, Karamoulas V, Bikos C. Intra-articular injection of tranexamic acid reduce blood loss in cemented total knee arthroplasty. Eur J Orthop Surg Traumatol . 2015;25(7):1181–1188.Google Scholar
- 5.Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Pérez-Chrzanowska H, Figueredo-Zalve R. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am. 2014;96(23):1937–1944.CrossRefPubMedGoogle Scholar
- 11.Rodriguez-Merchan EC, Ortega-Andreu M, Padilla-Eguiluz NG, Gomez-Cardero P, Martinez-Lloreda A, Gomez-Barrena G. Low-volume formulation of intra-articular tranexamic acid, 25-ml tranexamic acid (2.5 g) plus 20-ml saline, is effective in decreasing blood transfusion rate in primary total knee replacement even without preoperative haemoglobin optimization. Blood Coagul Fibrinolysis. 2016;27(6):660–666CrossRefPubMedGoogle Scholar
- 16.Watts CD, Pagnano MW. Minimising blood loss and transfusion in contemporary hip and knee arthroplasty. J Bone Joint Surg Br. 2012;94(11 Suppl A):8–10.Google Scholar